Blocknomi
Key Highlights MRNA stock climbed 3.37% in pre-market hours following nationwide FDA authorization of mFLUSIVA. FDA granted authorization for mFLUSIVA targeting all adults 50 years and above throughout the United…
Related articles
-
What Is an Air-Gapped Bitcoin Wallet? Why the Coldcard Exploit Changes the Conversation About Offline Security
Decrypt Published 03.08.2026 20:39
-
Cardano’s 24% Rally Sees Wallet Numbers Shrink as Stronger Hands Accumulate
BlockchainReporter Published 04.08.2026 09:30
-
BNY to offer institutional crypto staking through Galaxy partnership
Cointelegraph Published 04.08.2026 17:10
-
Hyperliquid, Multicoin back CFTC prediction market rules
Crypto.News Published 27.07.2026 13:23
-
Strategy Inc. (MSTR) Stock Gains as Company Boosts Cash Reserves by $525M and Buys Back Preferred Shares
Blocknomi Published 27.07.2026 15:18
-
Morning Minute: Bitcoin's New $15M Quantum Defense Fund
Decrypt Published 24.07.2026 12:29
-
JPYC Raises $38M as Yen Stablecoin Rolls out to Truck Drivers
Bitcoin.com Published 06.08.2026 17:50
-
Scaramucci Says CLARITY Act’s Crypto Ethics Isn’t Enough, Wants Insider Trading Gone
BeInCrypto Published 23.07.2026 02:10